Product Management Service (PMS) public API beta release - Technical overview and live demo, Online, from 13 July 2026, 14:00 (CEST) to 13 July 2026, 15:30 (CEST)

Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Anktiva, nogapendekin alfa inbakicept, Date of authorisation: 16/02/2026, Revision: 1, Status: Authorised

PSUSA/00010217/202509

Human medicines European public assessment report (EPAR): Tenofovir disoproxil Zentiva, tenofovir disoproxil, Date of authorisation: 15/09/2016, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Teriflunomide Viatris (previously Teriflunomide Mylan), teriflunomide, Date of authorisation: 09/11/2022, Revision: 9, Status: Authorised

Withdrawn application: Pluvicto, 23/04/2026

Human medicines European public assessment report (EPAR): Brineura, cerliponase alfa, Date of authorisation: 30/05/2017, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): DuoPlavin, clopidogrel,acetylsalicylic acid, Date of authorisation: 14/03/2010, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Livtencity, maribavir, Date of authorisation: 09/11/2022, Revision: 8, Status: Authorised